![glp-1 receptor agonists weight loss For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH glp-1_analogs [TUSOM | Pharmwiki]](https://b1167102.smushcdn.com/1167102/wp-content/uploads/2025/07/GLP01.jpg?lossy=2&strip=1&webp=1)
glp-1 receptor agonists weight loss For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH glp-1_analogs [TUSOM | Pharmwiki]
Description
These improvements in healthcare infrastructure increase the availability and affordability of insulin and GLP-1 receptor agonists, hence supporting market expansion
![glp-1 receptor agonists weight loss For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
Like virtually all medications, incretin mimetics come with side-effects, leading some patients to abandon treatment
![glp-1 receptor agonists weight loss For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH glp-1_analogs [TUSOM | Pharmwiki]](https://figures.semanticscholar.org/aa3600e85377b26b0c6657437594da51dba23a71/3-Figure1-1.png)
Liraglutide reduced the severity of acute myocardial infarction in control but not in Glp1r Tie2/ mice
![glp-1 receptor agonists weight loss For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH glp-1_analogs [TUSOM | Pharmwiki]](https://www.mdpi.com/cells/cells-13-00065/article_deploy/html/images/cells-13-00065-g001.png)
PLoS ONE 7 , e39656 (2012)
![glp-1 receptor agonists weight loss For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH glp-1_analogs [TUSOM | Pharmwiki]](https://images.ctfassets.net/4f3rgqwzdznj/2zOOXVnmS5ExpkOMLBGlOZ/9626d72ba81ecfb39b173a74b699ced2/23-02_Comparison_of_GLP-1_Agonist_Drugs.png)
Patients with eating disorders, extreme frailty or very low BMI may experience more harm than benefit
![glp-1 receptor agonists weight loss For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH glp-1_analogs [TUSOM | Pharmwiki]](https://sydenhamclinic.com/wp-content/uploads/2022/08/9185eb_20772a96806a4dd291c540ad345b6df7_mv2.webp)
